Terns Pharmaceuticals Stock In The News
| TERN Stock | USD 5.71 0.11 1.96% |
Our overall analysis of Terns Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Terns Pharmaceuticals. The specific impact of Terns Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Terns Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Terns Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Terns Pharmaceuticals Backtesting and Terns Pharmaceuticals Hype Analysis. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.
Terns |
Terns Pharmaceuticals Today Top News and Investor Outlook
Terns Pharmaceuticals Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Terns and other traded companies coverage with news coverage. We help investors stay connected with Terns headlines for the 22nd of November to make an informed investment decision based on correlating the impacts of news items on Terns Stock performance. Please note that trading solely based on the Terns Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Terns Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Terns earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Terns Pharmaceuticals that are available to investors today. That information is available publicly through Terns media outlets and privately through word of mouth or via Terns internal channels. However, regardless of the origin, that massive amount of Terns data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Terns Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Terns Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Terns Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Terns Pharmaceuticals alpha.
Terns Largest EPS Surprises
Earnings surprises can significantly impact Terns Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-12 | 2024-09-30 | -0.32 | -0.28 | 0.04 | 12 | ||
2024-05-13 | 2024-03-31 | -0.34 | -0.3 | 0.04 | 11 | ||
2023-05-15 | 2023-03-31 | -0.27 | -0.31 | -0.04 | 14 | ||
2022-03-03 | 2021-12-31 | -0.63 | -0.56 | 0.07 | 11 | ||
2022-11-09 | 2022-09-30 | -0.52 | -0.44 | 0.08 | 15 | ||
2023-08-08 | 2023-06-30 | -0.34 | -0.25 | 0.09 | 26 |
Terns Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Terns Pharmaceuticals Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
20th of November 2024
Terns Pharmaceuticals Stock Drops Over 5 percent Amidst Mixed Industry Performance at gurufocus.com
18th of November 2024
Insider Trading at gurufocus.com
14th of November 2024
We Think Terns Pharmaceuticals Can Afford To Drive Business Growth at finance.yahoo.com
12th of November 2024
Terns Pharmaceuticals Inc Reports Q3 2024 Net Loss Per Share of 0. ... at gurufocus.com
31st of October 2024
Terns Pharmaceuticals Coverage Initiated by Analysts at Oppenheimer at thelincolnianonline.com
15th of October 2024
Terns Pharmaceuticals, Inc. Sees Significant Increase in Short Interest at thelincolnianonline.com
30th of September 2024
Terns Pharmaceuticals stock target lifted on obesity drug data - Investing.com at news.google.com
24th of September 2024
Insiders Snap Up These 2 Strong Buy Stocks - Markets Insider at news.google.com
17th of September 2024
OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc at gurufocus.com
11th of September 2024
Terns Pharmaceuticals prices 150M stock offering at seekingalpha.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Terns Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Terns Pharmaceuticals' short interest history, or implied volatility extrapolated from Terns Pharmaceuticals options trading.
Check out Terns Pharmaceuticals Backtesting and Terns Pharmaceuticals Hype Analysis. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Revenue Per Share 0.035 | Return On Assets (0.19) | Return On Equity (0.28) |
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.